* IRIDEX Corp IRIX.OQ IRIX.O is expected to show a rise
in
quarterly revenue when it reports results on November 10.
* The Mountain View California-based company is expected to
report a 4.5% increase in revenue to $13.867 million from
$13.26 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for IRIDEX Corp is for
a loss
of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for IRIDEX Corp
is
$6.5, above its last closing price of $2.02.
This summary was machine generated November 9 at 03:01 GMT. All
figures in US dollars unless otherwise stated